PHARMA VISION
ActiveSummary
PHARMA VISION has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €56k and a net result of €134k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 18% of 37956 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
67
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency41▼-12
Growth58=
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity tight (current ratio 1.21 against 1.39 in 2023; short-term debt: 81.3% and cash: 13.6% of total assets), and 83.6% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 37956 sector peers (2024).
NBB · sector comparisonPosition among 37956 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 16-09-2025, 47 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
47 d late
2023
28 d early
2022
28 d late
2021
3 d early
2020
12 d late
2019
8 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€56k▼ 40.3%
2023 · €93k
2018: €95k
2019: €95k
2020: €95k
2021: €95k
2022: €95k
2023: €93k
2018 → 2024
Total assets
€341k▲ 2.7%
2023 · €332k
2018: €334k
2019: €363k
2020: €320k
2021: €388k
2022: €399k
2023: €332k
2018 → 2024
Net result
€134k▲ 61.4%
2023 · €83k
2018: €71k
2019: €81k
2020: €105k
2021: €206k
2022: €131k
2023: €83k
2018 → 2024
Working capital
€58k▼ 37.1%
2023 · €92k
2018: €69k
2019: €73k
2020: €77k
2021: €84k
2022: €92k
2023: €92k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€95k-€95k=€95k=€93k▼ 1.5%€56k▼ 40.3%
Operating result€150k-€280k▲ 87.0%€186k▼ 33.8%€125k▼ 32.8%€215k▲ 72.6%
Net result€105k-€206k▲ 96.8%€131k▼ 36.4%€83k▼ 36.6%€134k▲ 61.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 73% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €341k
Fixed assets
€6k ▲ 26.8%
Current assets
€335k ▲ 2.3%
Equity and liabilities €341k
Equity
€56k ▼ 40.3%
Debt
€285k ▲ 19.5%
Debt's share of the balance-sheet total rises from 71.9% to 83.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€218k▲
2023 · €128k
Cash flow
€137k▲
2023 · €86k
Current ratio
1.21▼
2023 · 1.39
Debt to equity
5.11▲
2023 · 2.56
ROE
240.8%▲
2023 · 89.0%
ROA
39.4%▲
2023 · 25.0%
Interest coverage
10.30▼
2023 · 15.37
Debt ≤ 1 year
€277k▲
2023 · €236k
Income taxes
€62k▲
2023 · €34k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 47 lines
Balance sheet
Code20232024
Assets
Total assets20/58€332k€341k▲
Fixed assets21/28€5k€6k▲
Tangible fixed assets22/27€4k€5k▲
Furniture and vehicles24€4k€5k▲
Financial fixed assets28€1k€1k=
Current assets29/58€328k€335k▲
Amounts receivable within one year40/41€94k€216k▲
Trade receivables40€30k€137k▲
Other amounts receivable41€64k€79k▲
Current investments50/53€54k€68k▲
Cash at bank and in hand54/58€176k€47k▼
Deferred charges and accrued income490/1€4k€4k▲
Equity and liabilities
Total equity and liabilities10/49€332k€341k▲
Equity10/15€93k€56k▼
Contributions10/11€12k€12k=
Reserves13€81k€43k▼
Distributable reserves133€81k€43k▼
Amounts payable17/49€239k€285k▲
Amounts payable within one year42/48€236k€277k▲
Financial debts43€62k€67k▲
Credit institutions430/8€62k€67k▲
Trade debts44€3k€3k▲
Suppliers440/4€3k€3k▲
Taxes, remuneration and social security45€109k€73k▼
Taxes450/3€106k€73k▼
Remuneration and social security454/9€3k-
Other amounts payable47/48€62k€134k▲
Accrued charges and deferred income492/3€3k€8k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€2k▼
Other operating charges640/8€4k€6k▲
Non-recurring operating charges66A€175-
Gross operating margin9900€132k€224k▲
Operating profit (loss)9901€125k€215k▲
Financial income75/76B€220€2k▲
Recurring financial income75€220€2k▲
Financial charges65/66B€8k€21k▲
Recurring financial charges65€8k€21k▲
Profit (loss) for the period before taxes9903€117k€196k▲
Income taxes67/77€34k€62k▲
Profit (loss) for the period9904€83k€134k▲
Profit (loss) for the period to be appropriated9905€83k€134k▲
Appropriation of the result
Profit (loss) to be appropriated9906€83k€134k▲
Transfer from equity791/2€23k€38k▲
Transfer to equity691/2€22k-
To other reserves6921€22k-
Profit to be distributed694/7€85k€172k▲
Return on contributions (dividend)694€85k€172k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
16-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 47 days late
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
28-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Highest result since 2018net €206k ▲96.8%
Operating result €280k, net result €206k, both a record.
12-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 12 days late
2020
23-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
14-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 14 days late
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
25-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
2014
11-09
State Gazette act
Incorporation · Founding capital
Corporate purpose · Founder
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Agatha-Berchem · 1 establishment unit since 2005
Ground area
2.1 ha
Building footprint
746 m²
Volume, LiDAR
9,786 m³
2 parcels, Brussels · tallest building 23.2 m, ±7 floors. Linked by address, not a title deed.
16
companies at this address
See who is registered here
1 establishment unit
PHARMA VISION
since 20052.148.848.621
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21523B0887/00D000 | Brussels | 1.8 ha | 1 · 302 m² | 23.2 m · 7 fl. |
| 21342B0043/00X003 | Brussels | 2,978 m² | 1 · 444 m² | 10.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
POSTEP
BE 0849.728.611
Arlon · Eq €55,789
D-Tectonics
BE 0671.481.906
Antwerpen · Eq €55,790
2NRICH
BE 0798.868.046
Mechelen · Eq €55,791
AMP INNOVATION
BE 0821.837.547
Waterloo · Eq €55,779
Audacealys
BE 1003.986.622
Heusden-Zolder · Eq €55,773
Of 82,553 companies in sector 70200 we hold annual accounts for 52,572. 38,621 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-08-2005
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.